Teva Pharmaceutical Industries Ltd Stock Ownership - Who owns Teva Pharmaceutical Industries?


Insider buying vs selling

Have Teva Pharmaceutical Industries Ltd insiders been buying or selling?
David Matthew StarkExec. VP Chief Legal Officer2022-07-2858,163$9.04
Hafrun FridriksdottirExecutive VP Global R&D2022-05-17130,000$8.22
David Matthew StarkExec. VP Chief Legal Officer2022-03-079,057$7.37
Eric DrapeExecutive VP Global Operations2022-03-0711,334$7.37
Richard DaniellExec. VP European Commercial2022-03-0722,576$7.37
Hafrun FridriksdottirExecutive VP Global R&D2022-03-078,941$7.37
Sven DethlefsEVP North America Commercial2022-03-076,993$7.37
Eric DrapeExecutive VP Global Operations2022-03-0417,157$7.48
David Matthew StarkExec. VP Chief Legal Officer2022-03-0417,008$7.48
David Matthew StarkExec. VP Chief Legal Officer2022-03-046,246$7.48

1 of 3

TEVA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

TEVA Shareholders

What type of owners hold Teva Pharmaceutical Industries Ltd stock?
Capital Research Global Investors8.39%93,166,283$1.04BInstitution
Blackrock Inc3.88%43,077,603$482.47MInstitution
Abrams Capital Management LP2.17%24,046,356$269.32MInstitution
Menora Mivtachim Holdings Ltd2.10%23,310,610$261.08MInstitution
Migdal Insurance Financial Holdings Ltd1.76%19,532,920$218.77MInstitution
Clal Insurance Enterprises Holdings Ltd1.71%18,962,766$212.38MInstitution
Phoenix Holdings Ltd1.67%18,529,789$207.53MInstitution
State Street Corp1.25%13,846,013$155.08MInstitution
Harel Insurance Investments Financial Services Ltd1.03%11,447,527$128.21MInstitution
Capital International Investors0.96%10,682,878$119.65MInstitution

1 of 3

TEVA vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TEVA44.85%0.75%Net SellingNet Selling
VTRS72.29%17.41%Net SellingNet Selling
ELAN90.51%9.49%Net SellingNet Buying
PRGO61.42%38.58%Net Buying

Teva Pharmaceutical Industries Stock Ownership FAQ

Who owns Teva Pharmaceutical Industries?

Teva Pharmaceutical Industries (NYSE: TEVA) is owned by 44.85% institutional shareholders, 0.75% Teva Pharmaceutical Industries insiders, and 54.40% retail investors. Capital Research Global Investors is the largest individual Teva Pharmaceutical Industries shareholder, owning 93.17M shares representing 8.39% of the company. Capital Research Global Investors's Teva Pharmaceutical Industries shares are currently valued at $1.03B.

If you're new to stock investing, here's how to buy Teva Pharmaceutical Industries stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.